Short term effect of sacubitril/valsartan on comprehensive geriatric assessment in chronic heart failure: a real life analysis-Reference-Cited by-同舟云学术

Short term effect of sacubitril/valsartan on comprehensive geriatric assessment in chronic heart failure: a real life analysis

Published:2022-12-07 Issue:1 Volume:18 Page:113-125
ISSN:1828-0447
Container-title:Internal and Emergency Medicine
language:en
Short-container-title:Intern Emerg Med

Author:

Armentaro Giuseppe,Condoleo Valentino,Pelaia Corrado,Cassano Velia,Miceli Sofia,Maio Raffaele,Salzano Andrea,Pelle Maria Chiara,Perticone Maria,Succurro Elena,Arturi Franco,Andreozzi Francesco,Sesti Giorgio,Sciacqua Angela^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Emergency Medicine,Internal Medicine

Link

https://link.springer.com/content/pdf/10.1007/s11739-022-03130-6.pdf

Reference59 articles.

1. de Frutos F, Mirabet S, Ortega-Paz L, Buera I, Darnés S, Farré N, Perez B, Adeliño R, Bascompte R, Pérez-Rodón J, Aparicio X, Sutil-Vega M, Soto A et al (2020) Management of heart failure with reduced ejection fraction after ESC 2016 heart failure guidelines: the Linx registry. ESC Heart Fail. https://doi.org/10.1002/ehf2.12567

2. Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ, Falk V, González-Juanatey JR, Harjola VK, Jankowska EA, Jessup M, Linde C, Nihoyannopoulos P et al (2016) ESC guidelines for the diagnosis treatment of acute chronic heart failure: the task force for the diagnosis treatment of acute chronic heart failure of the European society of cardiology (ESC). developed with the special contribution of the heart failure association (HFA) of the ESC. Eur J Heart Fail 18:891–975. https://doi.org/10.1002/ejhf.592

3. Rich MW (2003) Drug therapy of heart failure in the elderly. Am J Geriatr Cardiol 12:235–242. https://doi.org/10.1111/j.1076-7460.2003.02013.x

4. Jersey C, Kumar D, Yongfei W, Harlan MK (2013) National trends in heart failure hospital stay rates, 2001 to 2009. J Am Coll Cardiolo 61(10):1778–1788. https://doi.org/10.1016/j.jacc.2012.11.057

5. Gale SE, Mardis A, Plazak ME, Kukin A, Reed BN (2021) Management of noncardiovascular comorbidities in patients with heart failure with reduced ejection fraction. Pharmacotherapy 41(6):537–545. https://doi.org/10.1002/phar.2528

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Use and Benefit of Sacubitril/Valsartan in Elderly Patients with Heart Failure with Reduced Ejection Fraction;Journal of Clinical Medicine;2024-08-14

2. Effects of SGLT2-Inhibitors on Comprehensive Geriatric Assessment, Biomarkers of Oxidative Stress, and Platelet Activation in Elderly Diabetic Patients with Heart Failure with Preserved Ejection Fraction;International Journal of Molecular Sciences;2024-08-13

3. Effect of Sacubitril/Valsartan on Cognitive Function in Patients With Heart Failure With Preserved Ejection Fraction: A Prespecified Analysis of PARAGON-HF;Circulation;2024-07-23

4. Exercise for frailty research frontiers: a bibliometric analysis and systematic review;Frontiers in Medicine;2024-05-01

5. Association of sodium–glucose cotransporter 2 inhibitors with changes in comprehensive geriatric assessment in elderly diabetic patients with heart failure: Data from MAGIC‐HF;European Journal of Heart Failure;2024-04